Tuesday, February 14, 2012
Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

Long-acting drug approved for schizophrenia

(HealthDay News) UPDATED 2009-08-03
The U.S. Food and Drug Administration (FDA) has approved a sustained action form of the antipsychotic Invega for the treatment of schizophrenia. Invega Sustenna is a once-monthly injected medication designed to help prevent symptom relapses in schizophrenia patients who fail to take a more frequent dose of the medicine. FDA officials say the drug should be used with caution by people who have a history of seizure, diabetes, or low white cell count.  Read full story >
See all Schizophrenia News
Related: Invega Sustenna

People who read this also read...

  • How Long Does Schizophrenia Last?
  • Liquid Long Acting Methylphenidate
  • Schizophrenia Relapse
  • History Of Schizophrenia Treatment
  • Long Acting Dilaudid
  • What Is One Positive Symptom Of Schizophrenia?